Medtronic Return on Tangible Equity 2010-2025 | MDT

Current and historical return on tangible equity values for Medtronic (MDT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Medtronic Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-01-31 $4.26B $-3.39B -95.78%
2024-10-31 $4.29B $-4.87B -99.40%
2024-07-31 $3.93B $-5.74B -100.55%
2024-04-30 $3.68B $-3.79B -102.23%
2024-01-31 $4.20B $-2.85B -110.61%
2023-10-31 $4.10B $-3.23B -93.47%
2023-07-31 $3.62B $-4.50B -78.97%
2023-04-30 $3.76B $-4.60B -87.97%
2023-01-31 $4.06B $-5.21B -102.48%
2022-10-31 $4.32B $-4.02B -112.54%
2022-07-31 $5.21B $-3.26B -120.22%
2022-04-30 $5.04B $-3.38B -95.95%
2022-01-31 $4.91B $-4.71B -76.39%
2021-10-31 $4.70B $-5.98B -61.75%
2021-07-31 $3.88B $-6.95B -45.93%
2021-04-30 $3.61B $-8.10B -40.29%
2021-01-31 $2.89B $-9.45B -32.37%
2020-10-31 $3.54B $-9.31B -41.77%
2020-07-31 $4.41B $-8.94B -52.56%
2020-04-30 $4.79B $-8.03B -55.60%
2020-01-31 $5.32B $-7.59B -57.88%
2019-10-31 $4.67B $-9.01B -46.65%
2019-07-31 $4.42B $-9.82B -43.40%
2019-04-30 $4.63B $-10.31B -45.39%
2019-01-31 $4.92B $-10.90B -48.05%
2018-10-31 $2.26B $-9.71B -21.70%
2018-07-31 $3.16B $-9.90B -30.05%
2018-04-30 $3.10B $-10.44B -28.47%
2018-01-31 $2.81B $-11.63B -25.08%
2017-10-31 $5.02B $-10.12B -39.29%
2017-07-31 $4.12B $-11.42B -27.85%
2017-04-30 $4.03B $-11.59B -24.96%
2017-01-31 $3.97B $-17.94B -22.91%
2016-10-31 $4.24B $-18.15B -24.87%
2016-07-31 $3.65B $-16.85B -21.84%
2016-04-30 $3.54B $-16.34B -21.61%
2016-01-31 $2.43B $-16.88B -15.08%
2015-10-31 $2.32B $-16.74B -22.71%
2015-07-31 $2.62B $-15.55B -58.03%
2015-04-30 $2.68B $-15.40B 291.47%
2015-01-31 $3.12B $6.88B 48.74%
2014-10-31 $2.91B $5.98B 46.28%
2014-07-31 $2.98B $6.21B 48.04%
2014-04-30 $3.07B $6.56B 50.68%
2014-01-31 $3.59B $6.39B 61.57%
2013-10-31 $3.81B $5.67B 70.45%
2013-07-31 $3.56B $5.57B 68.71%
2013-04-30 $3.47B $5.67B 69.69%
2013-01-31 $3.49B $4.74B 74.36%
2012-10-31 $3.44B $4.73B 74.00%
2012-07-31 $3.66B $4.76B 82.45%
2012-04-30 $3.62B $4.53B 84.62%
2012-01-31 $3.40B $4.54B 83.57%
2011-10-31 $3.39B $3.92B 91.56%
2011-07-31 $3.09B $4.10B 85.00%
2011-04-30 $3.10B $3.72B 87.71%
2011-01-31 $3.28B $3.07B 93.07%
2010-10-31 $3.18B $3.63B 85.98%
2010-07-31 $3.48B $3.70B 98.22%
2010-04-30 $3.10B $3.68B 95.34%
2010-01-31 $2.25B $3.80B 75.92%
2009-10-31 $2.11B $3.01B 75.69%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $110.735B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.835B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 15.40
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00